Xanthone analogs for the treatment of infectious diseases
US5977077A · kind A · utility
10Cited by
23References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 1996 |
| Grant date | Nov 2, 1999 |
| Priority date | — |
| Expiry date | Mar 20, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic compositions for the treatment of infectious diseases are disclosed. These compositions comprise xanthones and xanthone derivatives, such as 2,3,4,5,6-pentahydroxyxanthone. Also disclosed are methods for the treatment of infectious diseases using such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.